Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Canal

Showing results (81-90 of 142) with videos related to

Pageof 15
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1997
Pharmacokinetic interrelationships of irinotecan (CPT-11) and its three major plasma metabolites in patients enrolled in phase I/II trialsL P Rivory, M C Haaz, P Canal, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 1991
Concomitant evaluation of efficiency, acute and delayed toxicities of combined treatment of radiation and CDDP on an in vivo modelA M Julia, P Canal, D Berg, et al.
Archives Francaises De Pediatrie|April 1, 1970
[Measurement of antibiotic activity in cerebrospinal fluid and treatment of purulent meningitis]A Raffi, M Véron, A Kasmierczak, et al.
Bulletin Du Cancer|January 1, 1989
[Comparison of the pharmacokinetics of cisplatin administered by the intraperitoneal route in 2 dosages: 100 and 200 mg/m2]P Canal, E Chatelut, M De Forni, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1989
Phase I/pharmacokinetic study of intraperitoneal teniposide (VM 26)P Canal, R Bugat, E Chatelut, et al.
Chirurgie Pediatrique|January 1, 1980
[Fractures of axis pedicles in battered infant (author's transl)]P Gille, J F Bonneville, J Y François, et al.
Bulletin Du Cancer|July 1, 1997
[Bayesian estimation of pharmacokinetic parameters of etoposide]E Evene, E Chatelut, B Tranchand, et al.
European Journal of Cancer (Oxford, England : 1990)|June 13, 1998
Co-variables influencing 5-fluorouracil clearance during continuous venous infusion. A NONMEM analysisM C Etienne, E Chatelut, X Pivot, et al.
Acta Medica Austriaca|January 1, 1989
Clinical and pharmacokinetic study of intraperitoneal cisplatin at two dose levels: 100 mg/m2 alone or 200 mg/m2 with i.v. sodium thiosulfateP Canal, M de Forni, E Chatelut, et al.
Anticancer Research|January 1, 1997
Pharmacokinetics of high-dose intravenous melphalan in patients undergoing peripheral blood hematopoietic progenitor-cell transplantationF Pinguet, P Martel, M Fabbro, et al.
Pageof 15

Showing results (81-90 of 142) with videos related to

Sort By:
Pageof 15
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1997
Pharmacokinetic interrelationships of irinotecan (CPT-11) and its three major plasma metabolites in patients enrolled in phase I/II trialsL P Rivory, M C Haaz, P Canal, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 1991
Concomitant evaluation of efficiency, acute and delayed toxicities of combined treatment of radiation and CDDP on an in vivo modelA M Julia, P Canal, D Berg, et al.
Archives Francaises De Pediatrie|April 1, 1970
[Measurement of antibiotic activity in cerebrospinal fluid and treatment of purulent meningitis]A Raffi, M Véron, A Kasmierczak, et al.
Bulletin Du Cancer|January 1, 1989
[Comparison of the pharmacokinetics of cisplatin administered by the intraperitoneal route in 2 dosages: 100 and 200 mg/m2]P Canal, E Chatelut, M De Forni, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1989
Phase I/pharmacokinetic study of intraperitoneal teniposide (VM 26)P Canal, R Bugat, E Chatelut, et al.
Chirurgie Pediatrique|January 1, 1980
[Fractures of axis pedicles in battered infant (author's transl)]P Gille, J F Bonneville, J Y François, et al.
Bulletin Du Cancer|July 1, 1997
[Bayesian estimation of pharmacokinetic parameters of etoposide]E Evene, E Chatelut, B Tranchand, et al.
European Journal of Cancer (Oxford, England : 1990)|June 13, 1998
Co-variables influencing 5-fluorouracil clearance during continuous venous infusion. A NONMEM analysisM C Etienne, E Chatelut, X Pivot, et al.
Acta Medica Austriaca|January 1, 1989
Clinical and pharmacokinetic study of intraperitoneal cisplatin at two dose levels: 100 mg/m2 alone or 200 mg/m2 with i.v. sodium thiosulfateP Canal, M de Forni, E Chatelut, et al.
Anticancer Research|January 1, 1997
Pharmacokinetics of high-dose intravenous melphalan in patients undergoing peripheral blood hematopoietic progenitor-cell transplantationF Pinguet, P Martel, M Fabbro, et al.
Pageof 15